Though more than one million people are thought to use the drug to treat ailments ranging from cancer to seizures to hepatitis C and chronic pain, there are few rigorous studies showing whether the drug is a fruitful treatment for those or any other conditions. A major reason is this: The federal government categorizes marijuana as a Schedule 1 drug, the most restrictive of five groups established by the Controlled Substances Act of 1970. Drugs in this category including heroin, LSD, peyote and Ecstasy are considered to have no accepted medical use in the United States and a high potential for abuse, and are subject to tight restrictions on scientific study. To obtain the drug legally, researchers like Dr. Sisley must apply to the Food and Drug Administration, the Drug Enforcement Administration and the National Institute on Drug Abuse which, citing a 1961 treaty obligation, administers the only legal source of the drug for federally sanctioned research, at the University of Mississippi. Dr. Sisley’s proposed study also had to undergo an additional layer of http://markets.housingwire.com/housingwire/news/read/26075459 review from the Public Health Service that is not required for other controlled substances in such research. The process is so cumbersome that a growing number of elected state officials, medical experts and members of Congress have started calling for loosening the restrictions. In June, a letter signed by 30 members of Congress, including four Republicans, called the extra scrutiny of marijuana projects “unnecessary,” saying that research “has often been hampered by federal barriers.” “It defies logic in this day and age that marijuana is still in Schedule 1 alongside heroin and LSD when there http://finance.kimt.com/inergize.kimt/news/read/26075459/ is so much testimony to what relief medical marijuana can bring,” Gov.
Full story: http://www.cnbc.com/id/101908928